News: Neuralstem Up on Alzheimer Data $CUR

Neuralstem Inc., shares up by 11% on the presentation of its Pre-market Pre-clinical data on “Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer.

The poster was presented at the International Society for Stem Cell Research Annual Meeting in Stockholm, Sweden.

View the full release here.